Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Fowler

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Biomolecular NMR Assignments|May 9, 2016
Backbone and side-chain chemical shift assignments for the C-terminal domain of Tcb2, a cytoskeletal calcium-binding protein from Tetrahymena thermophilaAdina M Kilpatrick, Theodore E Gurrola, Robert C Sterner, et al.
Biochemistry|January 8, 2013
Nuclear magnetic resonance solution structure of the peptidoglycan-binding SPOR domain from Escherichia coli DamX: insights into septal localizationKyle B Williams, Atsushi Yahashiri, S J Ryan Arends, et al.
Journal of Asthma and Allergy|July 15, 2021
Safety of Once-Daily Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol in Japanese Patients with Asthma: A Long-Term (52-Week) Phase III Open-Label StudySoichiro Hozawa, Hiroyuki Ohbayashi, Michiko Tsuchiya, et al.
NPJ Primary Care Respiratory Medicine|May 8, 2023
Suboptimally controlled asthma in patients treated with inhaled ICS/LABA: prevalence, risk factors, and outcomesShiyuan Zhang, John White, Alyssa Goolsby Hunter, et al.
Current Medical Research and Opinion|June 24, 2021
Efficacy and safety of once-daily, single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol in Japanese patients with inadequately controlled asthma: the CAPTAIN studyYoichi Nakamura, Soichiro Hozawa, Hironori Sagara, et al.
Chest|June 29, 2023
Clinic vs Home Spirometry for Monitoring Lung Function in Patients With AsthmaJohn Oppenheimer, Nicola A Hanania, Rekha Chaudhuri, et al.
Chembiochem : a European Journal of Chemical Biology|January 22, 2021
Fragment-Based Nuclear Magnetic Resonance Screen against a Regulator of G Protein Signaling Identifies a Binding "Hot Spot"Michael P Hayes, Joseph B O'Brien, Rachel A Crawford, et al.
The Journal of Biological Chemistry|April 4, 2019
High-resolution structure of RGS17 suggests a role for Ca<sup>2+</sup> in promoting the GTPase-activating protein activity by RZ subfamily membersMonita Sieng, Michael P Hayes, Joseph B O'Brien, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 1, 2013
In vivo monitoring of liposomal release in tumours following ultrasound stimulationTove J Evjen, Eirik Hagtvet, Alexei Moussatov, et al.
Respiratory Research|June 14, 2020
A phase IIb, randomised, parallel-group study: the efficacy, safety and tolerability of once-daily umeclidinium in patients with asthma receiving inhaled corticosteroidsEdward Kerwin, Steven Pascoe, Zelie Bailes, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Biomolecular NMR Assignments|May 9, 2016
Backbone and side-chain chemical shift assignments for the C-terminal domain of Tcb2, a cytoskeletal calcium-binding protein from Tetrahymena thermophilaAdina M Kilpatrick, Theodore E Gurrola, Robert C Sterner, et al.
Biochemistry|January 8, 2013
Nuclear magnetic resonance solution structure of the peptidoglycan-binding SPOR domain from Escherichia coli DamX: insights into septal localizationKyle B Williams, Atsushi Yahashiri, S J Ryan Arends, et al.
Journal of Asthma and Allergy|July 15, 2021
Safety of Once-Daily Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol in Japanese Patients with Asthma: A Long-Term (52-Week) Phase III Open-Label StudySoichiro Hozawa, Hiroyuki Ohbayashi, Michiko Tsuchiya, et al.
NPJ Primary Care Respiratory Medicine|May 8, 2023
Suboptimally controlled asthma in patients treated with inhaled ICS/LABA: prevalence, risk factors, and outcomesShiyuan Zhang, John White, Alyssa Goolsby Hunter, et al.
Current Medical Research and Opinion|June 24, 2021
Efficacy and safety of once-daily, single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol in Japanese patients with inadequately controlled asthma: the CAPTAIN studyYoichi Nakamura, Soichiro Hozawa, Hironori Sagara, et al.
Chest|June 29, 2023
Clinic vs Home Spirometry for Monitoring Lung Function in Patients With AsthmaJohn Oppenheimer, Nicola A Hanania, Rekha Chaudhuri, et al.
Chembiochem : a European Journal of Chemical Biology|January 22, 2021
Fragment-Based Nuclear Magnetic Resonance Screen against a Regulator of G Protein Signaling Identifies a Binding "Hot Spot"Michael P Hayes, Joseph B O'Brien, Rachel A Crawford, et al.
The Journal of Biological Chemistry|April 4, 2019
High-resolution structure of RGS17 suggests a role for Ca<sup>2+</sup> in promoting the GTPase-activating protein activity by RZ subfamily membersMonita Sieng, Michael P Hayes, Joseph B O'Brien, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 1, 2013
In vivo monitoring of liposomal release in tumours following ultrasound stimulationTove J Evjen, Eirik Hagtvet, Alexei Moussatov, et al.
Respiratory Research|June 14, 2020
A phase IIb, randomised, parallel-group study: the efficacy, safety and tolerability of once-daily umeclidinium in patients with asthma receiving inhaled corticosteroidsEdward Kerwin, Steven Pascoe, Zelie Bailes, et al.
Pageof 6